Lancet review of cannabis legalization warns commercialization may repeat the public health harms of alcohol and tobacco industries
A comprehensive Lancet review finds cannabis legalization has increased use in some populations and raised concerns about road crashes, while warning that commercial cannabis industries may follow the harmful marketing patterns of alcohol and tobacco.
Quick Facts
What This Study Found
Cannabis legalisation has been associated with increased use in some populations and possible increases in road crashes. Medicinal cannabis regulations may have increased recreational use. The review warns that profit-driven commercial cannabis industries may resist effective regulation, as seen with alcohol and tobacco.
Key Numbers
Cannabis is the most commonly used illicit drug globally. Legalization associated with increased use in some populations. Road crash concerns documented. Alcohol and tobacco policy examples used to project long-term cannabis industry effects.
How They Did This
Comprehensive review published in The Lancet assessing public health impacts of cannabis legalization in the Americas, covering use patterns, health effects, medicinal evidence, regulatory approaches, effects on use and harms, and policy recommendations.
Why This Research Matters
Published in one of the world's top medical journals, this is the most authoritative overview of legalization's public health implications. Its warning about commercial cannabis following the alcohol/tobacco playbook is particularly relevant for countries still deciding on legalization models.
The Bigger Picture
The review draws a critical historical parallel: alcohol and tobacco industries consistently opposed effective regulation despite known harms. If cannabis follows the same commercial model, public health measures like advertising restrictions, plain packaging, and taxation may face industry resistance.
What This Study Doesn't Tell Us
Most legalization data comes from US states and Canada with relatively short follow-up periods. Long-term effects are projected from alcohol/tobacco analogies, which may not perfectly predict cannabis industry behavior. Policy recommendations may not apply to all regulatory contexts.
Questions This Raises
- ?Can cannabis legalization models avoid the harms of commercial alcohol and tobacco?
- ?What is the optimal tax rate to minimize harms without creating a black market?
- ?Would government-run monopoly models outperform commercial models for public health?
Trust & Context
- Key Stat:
- Lancet warns commercial cannabis may follow alcohol/tobacco industry's resistance to regulation
- Evidence Grade:
- Strong: comprehensive review published in The Lancet synthesizing evidence across multiple policy domains.
- Study Age:
- Published in 2019.
- Original Title:
- Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.
- Published In:
- Lancet (London, England), 394(10208), 1580-1590 (2019)
- Authors:
- Hall, Wayne(24), Stjepanović, Daniel(11), Caulkins, Jonathan, Lynskey, Michael, Leung, Janni, Campbell, Gabrielle, Degenhardt, Louisa
- Database ID:
- RTHC-02060
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Has legalization made cannabis use more common?
According to this Lancet review, legalization has been associated with increased use in some populations, though the effects vary by jurisdiction. Medicinal cannabis regulations may have also increased recreational use.
What can we learn from alcohol and tobacco regulation?
The review warns that commercial cannabis industries will likely resist effective regulation just as alcohol and tobacco industries have. Policies like advertising bans, plain packaging, and taxation should be implemented proactively before industry lobbying makes them harder to enact.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- cannabis-relapse-cycle-pattern
- cold-turkey-vs-taper-quit-weed
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-quit-weed
- journaling-weed-withdrawal
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-02060APA
Hall, Wayne; Stjepanović, Daniel; Caulkins, Jonathan; Lynskey, Michael; Leung, Janni; Campbell, Gabrielle; Degenhardt, Louisa. (2019). Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.. Lancet (London, England), 394(10208), 1580-1590. https://doi.org/10.1016/S0140-6736(19)31789-1
MLA
Hall, Wayne, et al. "Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.." Lancet (London, 2019. https://doi.org/10.1016/S0140-6736(19)31789-1
RethinkTHC
RethinkTHC Research Database. "Public health implications of legalising the production and ..." RTHC-02060. Retrieved from https://rethinkthc.com/research/hall-2019-public-health-implications-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.